Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New tool could help millions ditch unnecessary antibiotic allergies

NCT ID NCT06771440

First seen Jan 05, 2026 · Last updated Jun 22, 2026 · Updated 25 times

Summary

This study tests a simple computer tool that checks medical records to see if patients with a reported antibiotic allergy can safely use that antibiotic again. Many antibiotic allergy labels are incorrect, leading to use of less effective or broader-spectrum antibiotics. The tool aims to safely remove or refine these labels without any skin tests or procedures. Researchers will study 3,000 hospitalized adults to see if using the tool improves antibiotic choice and patient outcomes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANTIBIOTIC ALLERGY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University Hospitals Leuven

    RECRUITING

    Leuven, Belgium

    Contact

    Contact Email: •••••@•••••

    Contact

    Contact Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

AAL-fact-check tool (a stored query in the electronic patient record that checks for safe re-exposure to antibiotics)

What this could lead to

If successful, this tool could help hospitals safely remove unnecessary antibiotic allergy labels, allowing more patients to receive first-line antibiotics and potentially reducing hospital stays.

What could go wrong

This is an early-stage study testing a tool, not a treatment. The tool may not change antibiotic use as expected, and results may not apply to all hospitals or patients.

Conditions

The condition(s) this trial relates to.

drug allergy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.